BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1962804)

  • 21. Biochemical effects of prolonged renin inhibition in marmosets.
    Wood JM; Jobber RA; Baum HP; de Gasparo M; Nussberger J
    J Hypertens; 1989 Aug; 7(8):615-8. PubMed ID: 2681408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo comparison of the renin inhibitor H77 with the angiotensin-converting enzyme inhibitor captopril.
    Oldham AA; Arnstein MJ; Major JS; Clough DP
    J Cardiovasc Pharmacol; 1984; 6(4):672-7. PubMed ID: 6206324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro and in vivo inhibition of renin by a thiazolylalanyl cyclostatine derivative].
    Muneta S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):865. PubMed ID: 2512401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses and biological activities of renin inhibitors containing statine analogues.
    Nishi T; Saito F; Nagahori H; Kataoka M; Morisawa Y; Yabe Y; Sakurai M; Higashida S; Shoji M; Matsushita Y
    Chem Pharm Bull (Tokyo); 1990 Jan; 38(1):103-9. PubMed ID: 2110866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of aging on the genetic expression of renin by mouse kidney.
    Hung L; Richardson A
    Aging (Milano); 1993 Jun; 5(3):193-8. PubMed ID: 8399464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained reduction in blood pressure during chronic administration of a renin inhibitor to normotensive marmosets.
    Wood JM; Baum HP; Jobber RA; Neisius D
    J Cardiovasc Pharmacol; 1987; 10 Suppl 7():S96-8. PubMed ID: 2485073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of different drug interference with the renin-angiotensin system.
    Hofbauer KG; Fuhrer W; Heusser C; Wood JM
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S62-8. PubMed ID: 2412016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of angiotensin I converting enzyme inhibitor, SQ 14225, on renin production and release.
    Saruta T; Eguchi T; Yasui T; Nagahama S; Nakamura R; Kato E
    Nephron; 1981; 29(5-6):265-9. PubMed ID: 6172718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of adrenal renin messenger ribonucleic acid by dietary sodium chloride.
    Brecher AS; Shier DN; Dene H; Wang SM; Rapp JP; Franco-Saenz R; Mulrow PJ
    Endocrinology; 1989 Jun; 124(6):2907-13. PubMed ID: 2470583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II.
    Nakamura A; Iwao H; Fukui K; Kimura S; Tamaki T; Nakanishi S; Abe Y
    Am J Physiol; 1990 Jan; 258(1 Pt 1):E1-6. PubMed ID: 2405694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin and angiotensinogen mRNA expression in the kidneys of rats subjected to long-term bile duct ligation.
    Ubeda M; Matzilevich MM; Atucha NM; García-Estañ J; Quesada T; Tang SS; Ingelfinger JR
    Hepatology; 1994 Jun; 19(6):1431-6. PubMed ID: 8188173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Responses to renin inhibition in conscious primates.
    Humke U; Levens N; Wood J; Hofbauer K
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F179-86. PubMed ID: 1907105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and extra-renal renin gene expression in spontaneously hypertensive rats.
    Okura T; Kitami Y; Wakamiya R; Marumoto K; Iwata T; Hiwada K
    Blood Press Suppl; 1992; 3():6-11. PubMed ID: 1343292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition.
    Oikawa T; Freeman M; Lo W; Vaughan DE; Fogo A
    Kidney Int; 1997 Jan; 51(1):164-72. PubMed ID: 8995730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a specific and long-acting renin inhibitor in the marmoset.
    Wood JM; Gulati N; Forgiarini P; Fuhrer W; Hofbauer KG
    Hypertension; 1985; 7(5):797-803. PubMed ID: 3928488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of irbesartan with captopril effects on cardiac hypertrophy and gene expression in heart failure-prone male SHHF/Mcc-fa(cp) rats.
    Carraway JW; Park S; McCune SA; Holycross BJ; Radin MJ
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):451-60. PubMed ID: 10069682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo inhibition of human and primate renin by a new potent renin inhibitor: SR 42128.
    De Claviere M; Cazaubon C; Lacour C; Nisato D; Gagnol JP; Evin G; Corvol P
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S58-61. PubMed ID: 2412015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effect of a renin inhibitor in marmosets with a segmental renal infarction.
    Neisius D; Wood JM
    J Hypertens; 1987 Dec; 5(6):721-5. PubMed ID: 2828470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of arterial pressure and renal function during chronic renin inhibition.
    Hall JE; Mizelle HL
    J Hypertens; 1990 Apr; 8(4):351-9. PubMed ID: 2160492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.